Physician Wealth Advisors Inc. Invests $129,000 in Kimberly-Clark Co. (NYSE:KMB)

Physician Wealth Advisors Inc. acquired a new stake in Kimberly-Clark Co. (NYSE:KMB) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 987 shares of the company’s stock, valued at approximately $129,000.

Other large investors have also recently bought and sold shares of the company. FMR LLC increased its holdings in shares of Kimberly-Clark by 3.2% during the 3rd quarter. FMR LLC now owns 572,463 shares of the company’s stock valued at $81,450,000 after acquiring an additional 17,919 shares during the last quarter. Caisse DE Depot ET Placement DU Quebec grew its holdings in Kimberly-Clark by 140.6% during the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 433,409 shares of the company’s stock valued at $61,665,000 after purchasing an additional 253,283 shares during the last quarter. L.M. Kohn & Company bought a new position in shares of Kimberly-Clark in the third quarter valued at approximately $231,000. Erste Asset Management GmbH acquired a new stake in shares of Kimberly-Clark in the third quarter worth $5,616,000. Finally, Kestra Investment Management LLC bought a new stake in shares of Kimberly-Clark during the 3rd quarter worth $572,000. 76.29% of the stock is currently owned by institutional investors.

Kimberly-Clark Trading Up 0.1 %

Shares of KMB stock opened at $140.73 on Monday. The company has a debt-to-equity ratio of 7.05, a quick ratio of 0.54 and a current ratio of 0.80. The firm has a fifty day moving average of $136.12 and a 200-day moving average of $135.92. Kimberly-Clark Co. has a 52-week low of $123.84 and a 52-week high of $150.45. The stock has a market cap of $46.67 billion, a price-to-earnings ratio of 18.64, a P/E/G ratio of 4.46 and a beta of 0.36.

Kimberly-Clark (NYSE:KMB) last posted its earnings results on Tuesday, January 28th. The company reported $1.50 EPS for the quarter, hitting the consensus estimate of $1.50. Kimberly-Clark had a return on equity of 201.43% and a net margin of 12.69%. On average, equities research analysts forecast that Kimberly-Clark Co. will post 7.5 earnings per share for the current fiscal year.

Kimberly-Clark Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 2nd. Investors of record on Friday, March 7th will be given a dividend of $1.26 per share. The ex-dividend date of this dividend is Friday, March 7th. This represents a $5.04 dividend on an annualized basis and a dividend yield of 3.58%. This is a boost from Kimberly-Clark’s previous quarterly dividend of $1.22. Kimberly-Clark’s dividend payout ratio (DPR) is 66.75%.

Insider Buying and Selling at Kimberly-Clark

In other news, VP Andrew Drexler sold 10,838 shares of Kimberly-Clark stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $141.00, for a total value of $1,528,158.00. Following the completion of the transaction, the vice president now owns 7,720 shares in the company, valued at approximately $1,088,520. The trade was a 58.40 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 0.64% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have weighed in on the stock. Citigroup cut their target price on shares of Kimberly-Clark from $125.00 to $118.00 and set a “sell” rating for the company in a research report on Wednesday, January 15th. JPMorgan Chase & Co. decreased their target price on Kimberly-Clark from $140.00 to $124.00 and set an “underweight” rating for the company in a research note on Thursday, January 16th. Piper Sandler reaffirmed an “overweight” rating and issued a $158.00 price target (down from $161.00) on shares of Kimberly-Clark in a research report on Wednesday, January 29th. Barclays increased their price objective on Kimberly-Clark from $138.00 to $144.00 and gave the company an “equal weight” rating in a research report on Thursday. Finally, TD Cowen lowered shares of Kimberly-Clark from a “buy” rating to a “hold” rating and set a $145.00 target price on the stock. in a research report on Wednesday, January 8th. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $144.85.

Kimberly-Clark Company Profile

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.